(a) A manufacturer of an individualized investigational treatment or an eligible facility may:(1) Provide an individualized investigational treatment to an eligible patient without receiving compensation; or(2) Require an eligible patient to pay the costs associated with the manufacture of the individualized investigational treatment.
(1) Provide an individualized investigational treatment to an eligible patient without receiving compensation; or
(2) Require an eligible patient to pay the costs associated with the manufacture of the individualized investigational treatment.
(b) If an eligible patient dies while receiving individualized investigational treatment, the eligible patient's heirs are not liable for any outstanding debt to the manufacturer related to the individualized investigational treatment.